Navigation Links
Ajinomoto Co., Inc. Harnesses Amino Acid Power to Improve Sleep
Date:5/31/2011

FORT LEE, N.J., May 31, 2011 /PRNewswire/ -- Ajinomoto Food Ingredients announced that Ajinomoto Co., Inc., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, will showcase Glysom™ (www.glysom.com) during Sleep 2011, the 25th Annual Meeting of the Associated Professional Sleep Societies to be held in Minneapolis, June 11-15, 2011.

Glysom™ is the latest breakthrough in amino acid and sleep research.  Made from glycine, an amino acid that occurs naturally in the body, Glysom™ is scientifically proven to promote deeper, sounder and more satisfying sleep for occasional sleeplessness without morning drowsiness.* Developed by a team of Ajinomoto Co., Inc. scientists led by Dr. Makoto Bannai, one of the foremost authorities on glycine and its applications to sleep, Glysom™ is particularly effective in promoting the deep, non-REM sleep crucial to feeling refreshed and restored in the morning.*  

"Since not all sleep is created equal, it's not enough to simply increase the number of hours at sleep," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Glysom™ zeroes in on sleep quality, inducing the healthy deep sleep critical to optimal well-being."

Glycine, the amino acid that is produced naturally in the body and present in many healthy foods such as fish, meat and bean, has been extensively researched.  Dr. Bannai has led glycine research at Ajinomoto Co., Inc. since 2005.  In the past decade, he has authored or co-authored over 20 studies examining various mechanisms of improving sleep and the critical connection between glycine and enhanced sleep quality and daytime performance.   Among Dr. Bannai's key findings are an early appearance of slow wave sleep (SWS) and the reduction of deep (core) body temperature in early phases of sleep after glycine ingestion, all indicators of improved sleep quality.

Introduced in the US in May 2010, Glysom™ is available exclusively through medical professionals.  In the year since its introduction, approximately 70 medical establishments nationwide have begun recommending Glysom™ to patients who experience occasional sleeplessness.  

According to the Centers for Disease Control and Prevention (the CDC), insufficient sleep is a public health epidemic, with an estimated 50-70 million US adults having difficulties with sleep or wakefulness.  

In addition to Glysom™, Ajinomoto Food Ingredients' safe, effective nutraceutical solutions include Capsiate Natura®, a patented, side effect-free dietary supplement with natural capsinoids shown to boost the body's metabolism*; and Natura Guard BP™, a milk protein-derived nutraceutical to help maintain healthy blood pressure levels already within the normal range*.  These products are backed by rigorous clinical studies and are available exclusively through medical professionals.  For more information and a complete list of healthcare professionals that carry Ajinomoto Food Ingredients' nutraceuticals, visit www.capsiatenatura.com, www.glysom.com and www.naturaguardbp.com

About Ajinomoto Food Ingredients

Ajinomoto Food Ingredients delivers safe, effective ingredients whose functionality has been scientifically proven.  Our mission is the pursuit of better health through better nutrition.  Beginning with AJI-NO-MOTO® MSG, a highly versatile seasoning, our products have diversified to flavor seasonings (bonito, pork, chicken, and beef), sweeteners, savory sauces, enzymes, other food ingredients and nutritional supplements.  Based on the five basic tastes centering on Umami, Ajinomoto supplies ingredients with unique aroma, texture, kokumi (full-bodied taste) and nutritional functionality.  These ingredients make it possible for our customers to build strong brands and offer consumers great-tasting, nutritionally beneficial products.

About Ajinomoto Co., Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals.  For many decades, Ajinomoto has contributed to food culture and human health through wide-ranging application of amino acid technologies.  Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability.  Founded in 1909 and now operating in 23 countries, Ajinomoto had net sales of 1,170.8 billion yen (12.8 billion USD) in fiscal 2010.  For more about Ajinomoto (TYO: 2802), visit www.ajinomoto.com.

Glysom™ clinical studies are available on request.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


'/>"/>
SOURCE Ajinomoto Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
2. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
3. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
4. Research Team Clones Genes Responsible for Amino Acid Absorption
5. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
6. El Camino Hospital Expands Robotic Surgery Program
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Cysview(TM) (Hexaminolevulinate HCl) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
9. FDA Limits Acetaminophen in Prescription Combination Products; Requires Liver Toxicity Warnings
10. FDA Consumer Health Information - New Steps Aimed at Cutting Risks from Acetaminophen
11. Abuse Deterrent Hydrocodone / Acetaminophen Leads NDA Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):